- ►annals.org TM Beck, AA Ciociola, SE Jones, WH Harvey, … - Annals of internal medicine, 1993 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To evaluate the efficacy and safety of oral ondansetron (Zofran) ... Cited by 68 - Related articles - All 4 versions
LX Cubeddu, K Pendergrass, T Ryan, M York, … - American journal of clinical oncology, 1994 - journals.lww.com Ain J Clin Ornai (CCI) 17(2): IS7-14h. IVV4. ะบ 1994 Raven Press, Ltd.. New
Efficacy of Oral Ondansetron, A Selective Antagonist of 5-HT3 Receptors, in the
Treatment of Nausea and Vomiting Associated with Cyclophosphamide-Based ... Cited by 30 - Related articles - BL Direct - All 3 versions
- ►ascopubs.org [PDF] G Fraschini, A Ciociola, L Esparza, D … - Journal of Clinical Oncology, 1991 - jco.ascopubs.org Evaluation of Three Oral Dosages of Ondansetron in the Prevention of Nausea and
Emesis Associated With Cyclophosphamide-Doxorubicin Chemotherapy ... By
Giuseppe Fraschini, Arthur Ciociola, Laura Esparza, Deborah Templeton, ... Cited by 31 - Related articles - All 7 versions
DR Gandara, WH Harvey, GG Monaghan, EA … - Seminars in oncology, 1992 - ncbi.nlm.nih.gov Cisplatin may evoke both an acute emetic response during the first 24 hours
following treatment and a less well-recognized syndrome of delayed emesis. While
delayed emesis is usually less severe in terms of frequency of vomiting ... Cited by 45 - Related articles - All 2 versions
TM Beck - Seminars in oncology, 1992 - ncbi.nlm.nih.gov The selective 5-hydroxytryptamine3 antagonist ondansetron has been shown to be
effective in preventing nausea and vomiting associated with highly emetogenic
cisplatin chemotherapy. Two multicenter, placebo-controlled, ... Cited by 16 - Related articles - BL Direct - All 2 versions
J DiBenedetto, LX Cubeddu, T Ryan, JA Kish, … - Clinical therapeutics, 1995 - Elsevier This multicenter, randomized, double-blind study compared the efficacy and
tolerability of ondansetron 8 mg twice daily for 3 days with placebo in
preventing nausea and vomiting in 81 patients receiving cyclophosphamide- ... Cited by 11 - Related articles - BL Direct - All 4 versions
WN Hait - New England Journal of Medicine, 1990 - content.nejm.org Original Article from The New England Journal of Medicine --
Ondansetron and cisplatin-induced nausea and vomiting.
Cited by 8 - Related articles - All 2 versions
NW Marschner, M Adler, GA Nagel, D … - European journal of cancer (Oxford, England: 1990), 1991 - ncbi.nlm.nih.gov Ondansetron was compared with metoclopramide for antiemetic efficacy in a
randomised double-blind trial in 122 patients with advanced breast cancer. All
patients were treated with epirubicin (greater than 50 mg/m2) and ... Cited by 31 - Related articles - All 2 versions
ML Citron - Annals of internal medicine, 1993 - Am Coll Physicians Special ethical concerns exist about the use of placebo controls. A
placebo-controlled study must answer four questions: [1] Was any therapeutic
intervention available that could be reasonably assumed to be less harmful ... Cited by 19 - Related articles - All 3 versions
AA Fauser, B Duclos, A Chemaissani, A Del … - European Journal of Cancer, 1996 - Elsevier Pergamon BKmpeanM7M;t) CaMerVot.32A.No. 9, pp. 15231529,1996 Copyright 0 1996
Ebevier Science Ltd. AH rights reserved Printed in Great Britain 09598049 96
M5.00+OM Pn: 809598049(96)001323 Original Paper Therapeutic Equivalence of ... Cited by 31 - Related articles - BL Direct - All 4 versions
